Journal article
Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma
Abstract
This cohort study examines treatment with immune checkpoint inhibitors for patients with metastatic renal cell carcinoma.
Authors
Lalani A-KA; Bakouny Z; Farah S; Donskov F; Dudani S; Heng DYC; Choueiri TK
Journal
JAMA Oncology, Vol. 7, No. 5, pp. 773–775
Publisher
American Medical Association (AMA)
Publication Date
May 1, 2021
DOI
10.1001/jamaoncol.2021.0019
ISSN
2374-2437